Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Obesity is associated with an increased risk of developing breast cancer and is also associated with worse clinical prognosis. The mechanistic link between obesity and breast cancer progression remains unclear, and there has been no development of specific treatments to improve the outcome of obese cancer patients. Here we show that obesity-associated NLRC4 inflammasome activation/ interleukin (IL)-1 signalling promotes breast cancer progression. The tumour microenvironment in the context of obesity induces an increase in tumour-infiltrating myeloid cells with an activated NLRC4 inflammasome that in turn activates IL-1β, which drives disease progression through adipocyte-mediated vascular endothelial growth factor A (VEGFA) expression and angiogenesis. Further studies show that treatment of mice with metformin inhibits obesity-associated tumour progression associated with a marked decrease in angiogenesis. This report provides a causal mechanism by which obesity promotes breast cancer progression and lays out a foundation to block NLRC4 inflammasome activation or IL-1β signalling transduction that may be useful for the treatment of obese cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In those cases, IL-1β is the key player, acting as pro-inflammatory, tumor-promoting trigger [126,127,128,129,130].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [129]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zaafar, D. K., Zaitone, S. A., & Moustafa, Y. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100562 · Cited by 74 · cited 1×
“This is consistent with previous studies that have shown that metformin lowers serum VEGFA levels in both human and mouse 39,40 .”
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Whether obesity has an impact on these diseases through enhancement of inflammation or via a direct mechanism is largely unclear; however, obese adipose tissue is a reservoir for macrophages with activated inflammasomes that contribute to insulin resistance and diabetes 10,11 .”
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Metformin is known to have pleiotropic effects, and is thought to primarily work by inhibiting mitochondrial respiratory-chain complex-I, which leads to activation of adenosine monophosphate-activated protein kinase 38 .”
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“We We did observe a significant increase in the number of tumour-infiltrating macrophages (F4/80 þ CD11b þ ); in particular, there was a significant increase in CD11c (cid:2) macrophages and a trend for increased CD11c þ macrophages 21 (Fig.”
Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169 · cited 2×
“In addition, KMPlot (http://kmplot.com/analysis/) was used to analyse microarray data sets that were normalized and combined for survival analysis 41 .”
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Metformin, a type 2 diabetes drug, reduces the risk of several types of cancer including breast cancer 35–37 .”
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S.-S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,616
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 2×
“While in patients, obesity is associated with a worse clinical outcome and increased incidence of more aggressive triple-negative breast cancer regardless of menopausal status, these effects of obesity are exacerbated in postmenopausal women 2 .”
Sutterwala, F. S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G. S., Grant, E. P., Bertin, J., Coyle, A. J., Galán, J. E., Askenase, P. W., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.004 · Cited by 980
Self-citationImpact of Obesity and Metabolic Syndrome on Immunity
Andersen, C. J., Murphy, K. E., & Fernandez, M. L. (2016) · Advances in Nutrition · doi:10.3945/an.115.010207 · Cited by 701 · cited 1×
“Obesity and chronic inflammation are known risk factors for many chronic conditions including diabetes, cardiovascular disease and various cancers 7–9 .”
Kitamura, T., Qian, B.-Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Li, J., & Pollard, J. W. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141836 · Cited by 651 · cited 1×
“Obese tumour microenvironment recruits macrophages (likely via CCL2 chemotaxis 14,42 ) with an activated NLRC4 inflammasome that leads to IL-1 b activation.”
Tan, W., Zhang, W., Strasner, A., Grivennikov, S., Cheng, J. Q., Hoffman, R. M., & Karin, M. (2011) · Nature · doi:10.1038/nature09707 · Cited by 647
Self-citationHorai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M., & Iwakura, Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1463 · Cited by 611
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Markan, K. R., Naber, M. C., Ameka, M. K., Anderegg, M. D., Mangelsdorf, D. J., Kliewer, S. A., Mohammadi, M., & Potthoff, M. J. (2014) · Diabetes · doi:10.2337/db14-0595 · Cited by 590
Self-citationVerdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 495
Mehner, C., Hockla, A., Miller, E., Ran, S., Radisky, D. C., & Radisky, E. S. (2014) · Oncotarget · doi:10.18632/oncotarget.1932 · Cited by 368
Obesity and Cancer: The Oil that Feeds the Flame
Font-Burgada, J., Sun, B., & Karin, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.015 · Cited by 356
Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis
Lara-Tejero, M., Sutterwala, F. S., Ogura, Y., Grant, E. P., Bertin, J., Coyle, A. J., Flavell, R. A., & Galán, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060206 · Cited by 354
Self-citationKelly, B., Tannahill, G. M., Murphy, M. P., & O'Neill, L. A. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662114 · Cited by 334
Phosphorylation of NLRC4 is critical for inflammasome activation
Qu, Y., Misaghi, S., Izrael-Tomasevic, A., Newton, K., Gilmour, L. L., Lamkanfi, M., Louie, S., Kayagaki, N., Liu, J., Kömüves, L., et al. (2012) · Nature · doi:10.1038/nature11429 · Cited by 319
Metformin in cancer prevention and therapy.
Kasznicki, J., Śliwińska, A., & Drzewoski, J. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.01 · Cited by 316
Repurposing metformin for cancer treatment: current clinical studies
Chae, Y. K., Arya, A., Malecek, M.-K., Shin, D. S., Carneiro, B., Chandra, S., Kaplan, J., Kalyan, A., Altman, J. K., Platanias, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8194 · Cited by 316 · cited 1×
“While anti-VEGF therapy Avastin is not effective in breast cancer and the use of metformin in breast cancer is still undergoing in several clinical trials focused on obese patients 48 , these drugs still hold promise to be used in selective obese patient populations.”
Adipose Vascular Endothelial Growth Factor Regulates Metabolic Homeostasis through Angiogenesis
Sung, H.-K., Doh, K.-O., Son, J. E., Park, J. G., Bae, Y., Choi, S., Nelson, S. M. L., Cowling, R., Nagy, K., Michael, I. P., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.010 · Cited by 303 · cited 1×
“4e), in agreement with previous publications showing the positive correlation between BMI and serum VEGFA protein levels in human 29,30 and mouse 30,31 .”
Gilbert, C. A., & Slingerland, J. M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-121211-091527 · Cited by 302 · cited 1×
“Many factors have been proposed for obesity-driven breast-cancer progression (ODBP), including oestrogen, insulin resistance, the balance between adipokines, as well as pro-inflammatory cytokines including IL-6 and tumour necrosis factor-a 5 .”
Inflammasomes in cancer: a double-edged sword
Kolb, R., Liu, G.-H., Janowski, A. M., Sutterwala, F. S., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-013-0001-4 · Cited by 287
Self-citationObesity Promotes Breast Cancer by CCL2-Mediated Macrophage Recruitment and Angiogenesis
Arendt, L. M., McCready, J., Keller, P. J., Baker, D. D., Naber, S. P., Seewaldt, V., & Kuperwasser, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0926 · Cited by 265 · cited 3×
“Obese tumour microenvironment recruits macrophages (likely via CCL2 chemotaxis 14,42 ) with an activated NLRC4 inflammasome that leads to IL-1 b activation.”
Tolaney, S. M., Boucher, Y., Duda, D. G., Martin, J. D., Seano, G., Ancukiewicz, M., Barry, W. T., Goel, S., Lahdenrata, J., Isakoff, S. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518808112 · Cited by 258 · cited 1×
“Other inhibitors, including long-lasting CASP1 inhibitors 49 and other angiogenesis inhibitors, may also be beneficial for treating obese cancer patients with a high basal level of neoangiogenesis as has been recently indicated 50 , along with current standard therapies.”
Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.
Shornick, L. P., De Togni, P., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J., Karr, R. W., Ferguson, T. A., & Chaplin, D. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1427 · Cited by 237
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer
Lin, L., Chen, Y.-S., Yao, Y.-D., Chen, J.-Q., Chen, J.-N., Huang, S.-Y., Zeng, Y.-J., Yao, H.-R., Zeng, S.-H., Fu, Y.-S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5325 · Cited by 198 · cited 1×
“It has been shown that macrophages can secrete angiogenic factors other than IL-1 b 33 .”
Sulphonylureas and cancer: a case-control study
Monami, M., Lamanna, C., Balzi, D., Marchionni, N., & Mannucci, E. (2009) · Acta Diabetologica · doi:10.1007/s00592-008-0083-2 · Cited by 194 · cited 1×
“Metformin, a type 2 diabetes drug, reduces the risk of several types of cancer including breast cancer 35–37 .”
O'Connell, K. A., & Edidin, M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.521 · Cited by 177
The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
Ersoy, C., Kiyici, S. K., Budak, F., Oral, H. B., Güçlü, M., Duran, C., Selimoğlu, H., Ertürk, E., Tuncel, E., & İmamoğlu, Ş. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.02.006 · Cited by 132 · cited 1×
“This is consistent with previous studies that have shown that metformin lowers serum VEGFA levels in both human and mouse 39,40 .”
Sugiura, K., & Stock, C. C. (1952) · Cancer · doi:10.1002/1097-0142(195203)5:2<382::aid-cncr2820050229>3.0.co;2-3 · Cited by 118 · cited 1×
“E0771 cells are derived from a spontaneous breast adenocarcinoma in C57BL/6 mice 17 , and are characterized as luminal breast cancer 18 .”
Takemura, Y., Osuga, Y., Yoshino, O., Hasegawa, A., Hirata, T., Hirota, Y., Nose, E., Morimoto, C., Harada, M., Koga, K., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2486 · Cited by 117
Fuentes-Mattei, E., Velazquez-Torres, G., Phan, L., Zhang, F., Chou, P.-C., Shin, J.-H., Choi, H. H., Chen, J.-S., Zhao, R., Chen, J., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju158 · Cited by 114 · cited 4×
“Patient BMI data for GSE20194 were provided by Dr Sai-Ching Yeung (MD Anderson) 15 .”
InfluentialSelf-citationInterleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.
Rogers, H. W., Sheehan, K. C., Brunt, L. M., Dower, S. K., Unanue, E. R., & Schreiber, R. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.3.1011 · Cited by 108
Gómez‐Ambrosi, J., Catalán, V., Rodríguez, A., Ramírez, B., Silva, C., Gil, M. J., Salvador, J., & Frühbeck, G. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.05.004 · Cited by 103 · cited 2×
“4e), in agreement with previous publications showing the positive correlation between BMI and serum VEGFA protein levels in human 29,30 and mouse 30,31 .”
Wei, Z.-W., Xia, G., Wu, Y., Chen, W., Xiang, Z., Schwarz, R. E., Brekken, R. A., Awasthi, N., He, Y.-L., & Zhang, C.-H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.033 · Cited by 98 · cited 1×
“4a, left panels, red boxes indicate reference spots for loading), including the pro-angiogenic inflammatory chemokines CXCL1, CCL2 and CCL3 (refs 14,25,26; Fig.”
Loebig, M., Klement, J., Schmoller, A., Betz, S., Heuck, N., Schweiger, U., Peters, A., Schultes, B., & Oltmanns, K. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012610 · Cited by 92 · cited 1×
“4e), in agreement with previous publications showing the positive correlation between BMI and serum VEGFA protein levels in human 29,30 and mouse 30,31 .”
Reeves, G. K., Pirie, K., Green, J., Bull, D., Beral, V., & Collaborators, F. T. M. W. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.26460 · Cited by 86 · cited 1×
“Obesity is not only associated with an increased risk of oestrogen receptor (ER)-positive breast cancer in postmenopausal women, but also is associated with a worse clinical outcome independent of menopausal status 2–4 .”
NALP3: a key player in caspase-1 activation
Sutterwala, F. S., Ogura, Y., Zamboni, D. S., Roy, C. R., & Flavell, R. A. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120040701 · Cited by 84 · cited 1×
“Inflammasomes are a group of multiprotein complexes comprising NOD-like receptors (NLRP1, NLRP3 and NLRC4) and Pyrin member AIM2, the adaptor protein ASC and caspase 1 (CASP1), the latter being the common effector enzyme that cleaves pro-IL-1 b and pro-IL-18 to their active secreted forms 12 .”
Self-citationCurrent status of inflammasome blockers as anti-inflammatory drugs
López-Castejón, G., & Pelegrín, P. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.690032 · Cited by 75
Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells
Borcherding, N. C., Kusner, D. M., Kolb, R. H., Xie, Q. M., Li, W., Yuan, F., Velez, G., Askeland, R. W., Weigel, R. J., & Zhang, W. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2761 · Cited by 74
Self-citationLin, F., Lin, C., Chien, C., Luo, S., & Yang, C. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20142 · Cited by 72
Influence of obesity on breast cancer receptor status and prognosis
Rose, D. P., & Vona-Davis, L. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.71 · Cited by 71
Doxorubicin plus Interleukin-2 Chemoimmunotherapy against Breast Cancer in Mice
Ewens, A. D., Luo, L., Berleth, E. S., Alderfer, J. L., Wollman, R. M., Hafeez, B. B., Kanter, P. M., Mihich, E., & Ehrke, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3963 · Cited by 65 · cited 2×
“E0771 cells are derived from a spontaneous breast adenocarcinoma in C57BL/6 mice 17 , and are characterized as luminal breast cancer 18 .”
Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders
Pakradouni, J., Goff, W. L., Calmel, C., Antoine, B., Villard, E. F., Frisdal, É., Abifadel, M., Tordjman, J., Poitou, C., Bonnefont‐Rousselot, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066788 · Cited by 60 · cited 1×
“Other proteins that were increased in tumours from DIO mice included MMP9 that is known to promote cancer progression 27 and NOV (CCN3) that has been associated with obesity-related metabolic disorders 28 (Fig.”
Zhao, Y. M., Wang, Z., Jiang, Y., & Yang, C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.023 · Cited by 60
Biswas, T., Gu, X., Yang, J., Ellies, L. G., & Sun, L.-Z. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.018 · Cited by 52
Self-citationThe significant role of telomerase activity in human brain tumors
Nakatani, K., Yoshimi, N., Mori, H., Yoshimura, S.-I., Sakai, H., Shinoda, J., & Sakai, N. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3<421::aid-cncr10>3.0.co;2-z · Cited by 50
Barcelos, L. S., Coelho, A. M., Russo, R. C., Guabiraba, R., Souza, A. L. S., Bruno-Lima, G., Proudfoot, A. E. I., Andrade, S. P., & Teixeira, M. M. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.04.009 · Cited by 48
Inflammation as a Sensor of Metabolic Stress in Obesity and Type 2 Diabetes
Donath, M. Y. (2011) · Endocrinology · doi:10.1210/en.2011-1691 · Cited by 41
Overweight, Obesity, and All-Cause Mortality—Reply
Flegal, K. M., Kit, B. K., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2013.3101 · Cited by 30 · cited 1×
“O besity has an impact on 36% of US adults, and is attributed to B 16–20% of cancer deaths in women and 14% of cancer deaths in men 1 .”
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
The role of interleukin-1 in general pathology
Kaneko, N., Kurata, M., Yamamoto, T., Morikawa, S., & Masumoto, J. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0101-5 · Cited by 617
“A recent report showed that IL-1β orchestrates tumor-promoting inflammation in patients with high-risk HER2-negative breast cancer who would benefit from IL-1-blocking therapeutics with anakinra (described later on).”
BackgroundGut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
The obese adipose tissue microenvironment in cancer development and progression
Quail, D. F., & Dannenberg, A. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0126-x · Cited by 542
Metadata
- Authors
- Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., Fuentes-Mattei, E., Ellies, L. G., Knudson, C. M., Lee, M.-H., Yeung, S.-C. J., Cassel, S. L., Sutterwala, F. S., & Zhang, W.
- Affiliations
- University of Iowa (US)
- The University of Texas MD Anderson Cancer Center (US)
- Central South University (CN)
- University of California San Diego (US)
- Corresponding author
- Zhang, Weizhou
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-06
- Volume
- 7
- Issue
- 1
- Pages
- 13007-13007
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5059727
- OpenAlex
- W2529393815
- Cited by
- 239
- References
- 58
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 34 · 2022: 27 · 2021: 37 · 2020: 39 · 2019: 24 · 2018: 17 · 2017: 14 · 2016: 2
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NIH T32, KG081048, NIH-R01, AI118719, CA158055)
- University of Texas Health Science Center at San Antonio
- Holden Comprehensive Cancer Center, University of Iowa (P30-CA086862)
- National Cancer Institute (K99CA158055, CA203834, R00CA158055, R01CA200673, CA200673, L30 CA199587, R01CA203834, K22CA118182, P30CA086862)
- National Institute of Allergy and Infectious Diseases (R56AI118719, T32AI007260, R01AI104706, T32AI007485, T32AI007517)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK111758)
- National Institute on Minority Health and Health Disparities (L60 MD006355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- obesity, breast cancer progression, NLRC4 inflammasome, tumor microenvironment, VEGF-A, angiogenesis, adipocytes, metformin
- MeSH terms
- Animals, Breast, Breast Neoplasms, Calcium-Binding Proteins, Female, Humans, Mammary Neoplasms, Experimental, Mice, Inbred C57BL, Neoplasm Transplantation, Obesity, Signal Transduction, Lymphocytes, Tumor-Infiltrating, Disease Progression, Myeloid Cells, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.